Bharat biotech, Latest News
Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin
Bharat Biotech on Friday said it has terminated agreements it had signed with two Brazilian companies - Precisa Medicamentos and Envixia Pharmaceuticals LLC to introduce its Covid-19 Covaxin in Brazil. ...
COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week
As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday. ...
Zydus Cadila expected to provide additional data on Covid-19 vaccine to DCGI this week
Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India ...
Bharat Biotech dossier under review for Covaxin emergency use listing: WHO
Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use Listing (EUL) of Covaxin is under review by the technical experts for consideration, Dr Poon ...
Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech
With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global body at ...
Review process begins for WHO listing of Covaxin: Bharat Biotech
Hyderabad, July 12 Bharat Biotech on Monday said that it has submitted all documents to the World Health ... ...
EUL to Covaxin from WHO expected in first week of August: Sources
The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce it in the first week of August. ...
WHO to take decision on EUL of Covaxin in first week of August
The World Health Organization's (WHO) is likely to take decision on Emergency use Listing (EUL) of Bharat Biotech's COVID-19 ... ...
After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition
Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from ...
Final Phase-3 results of Covaxin show efficacy of 77.8% against Covid
New Delhi, July 3 Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic COVID-19, through ... ...